Zakrzewski Joseph S 4
4 · AN2 Therapeutics, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Purchase
Common Stock
2024-11-18$1.00/sh+20,000$19,996→ 118,199 total - Purchase
Common Stock
2024-11-19$1.01/sh+5,000$5,050→ 123,199 total
Holdings
- 405,880(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]These shares are held by Z3 Trust, for which the Reporting Person is a trustee.